VaramirStart free · no cardSign in
ELDN as of Oct 31 · 14:52 ET
ELDNNasdaqPharmaceutical Preparations

Eledon Pharmaceuticals, Inc. · Brief

Next report

13 days

Nov 13 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±26.3%
avg realized
±4.0%
Nov 12 '24±4.8%▼−11.41%×2.38
Mar 20 '25±28.3%▲+2.03%×0.07
May 14 '25±67.2%▲+2.12%×0.03
Aug 14 '25±8.5%▲+1.15%×0.14
Q3 FY25±32.9%▼−7.95%×0.24
Q1 FY26±15.7%▲+1.05%×0.07
May 13 '26±20.1%▲+1.80%×0.09
Q2 FY26±32.7%▼−4.32%×0.13
quarterimplied−70%0+70%realized×
Q2 FY26±32.7%▼−4.32%×0.13
May '26±20.1%▲+1.80%×0.09
Q1 FY26±15.7%▲+1.05%×0.07
Q3 FY25±32.9%▼−7.95%×0.24
Aug '25±8.5%▲+1.15%×0.14
May '25±67.2%▲+2.12%×0.03
2 older reports
Mar '25±28.3%▲+2.03%×0.07
Nov '24±4.8%▼−11.41%×2.38
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 13 report · est.

Bull2 of 3

+11.23%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
161managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

7 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
20managers whose positions together make up four fifths of reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ELDN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 30impliedImplied move: ±26.9% into Nov 13 earnings (Oct 30 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.